Rapport Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
RAPP
CUSIP
75383L102
Type
Equity
Class
COM
Num filings
83
Total reported value, excl. options
$438 M
Manager Report Date Value ($000) Shares Option Type